Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Lung Cancer Treatment Market
Lung Cancer Treatment Market Size
- Report ID: GMI5708
- Published Date: May 2023
- Report Format: PDF
Lung Cancer Treatment Market Size
Lung Cancer Treatment Market size was valued at USD 15.70 billion in 2022, and it is predicted to increase at a CAGR of 12.4% from 2023 and 2032 owing to rising demand for targeted therapies and increasing incidences of lung cancer across the globe
Lung cancer is one of the most common type of cancer and accounts for a significant number of cancer related deaths worldwide. Therefore, prevalence of lung cancer diseases is the major driver for the market. According to the International Agency for Research on Cancer's GLOBOCAN 2020 data, there were around 19.3 million new cases of cancer reported in 2020, with lungs cancer accounting for around 11.4%. The number of new cases of lung, trachea, and bronchus cancer in 2020 was estimated to be 2.21 million and is expected to reach 3.63 million by 2040
Lung cancer was the most common cause of death in 2020, accounting for over 18% of all deaths worldwide (1.8 million). Due to the increased frequency of smoking and second-hand smoke exposure, the global incidence of lung cancer is rapidly increasing.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| Lung Cancer Treatment Market Size in 2022: | USD 15.70 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 12.4% |
| 2032 Value Projection: | USD 49.44 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 182 |
| Tables, Charts & Figures: | 377 |
| Segments covered: | Type, Therapy, End-user, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Lung Cancer Treatment Market Scope
